BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Melanoma Institute Australia
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Brisbane
BEGIN:STANDARD
TZOFFSETFROM:+1000
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260703T170000
DTEND;TZID=Australia/Sydney:20260703T170000
DTSTAMP:20260602T044906Z
CREATED:20260602T044844Z
LAST-MODIFIED:20260602T044906Z
UID:10000305-1783098000-1783098000@melanoma.org.au
SUMMARY:SHP Pilot Grants
DESCRIPTION:SHP Pilot Grants – Funding to Test and Implement Research Into Clinical Practice \nEach year\, Sydney Health Partners funds pilot projects that help clinicians\, researchers and health professionals turn evidence into practical healthcare solutions and scale up the implementation of research for broader impact. \nIf you’re a health professional\, clinician\, or researcher leading research within Sydney Health Partners’ affiliated health services\, a Pilot Grant could help you to: \n\nTest real-world implementation of research innovations\nSolve complex health system challenges with practical solutions\nStrengthen applications for major funding bodies (NHMRC\, MRFF\, TRGS)\n\nApplications are now open for Sydney Health Partners 2026 Implementation Science Pilot Grants. \nSydney Health Partners are offering up to $220\,000 in grants to support up to 11 pilot projects\, with two of the projects to be funded by the Charles Perkins Centre Implementation Hub through the Jennie Mackenzie Research Fund. \nGrant Categories: \nStream 1: SHP Implementation Science Pilot Grants (up to 9) \nThese grants require two Principal Investigators (PIs):   \n\nOne from the University of Sydney or an SHP Partner Medical Research Institute (MRI)\n\n\nOne from an SHP Health Service Partner\n\nStream 2: CPC Implementation Hub Pilot Grants (x2) \nThese grants require two PIs – One must be a member of the Charles Perkins Centre: \n\nOne must be a University of Sydney or SHP Partner MRI employee\n\n\nOne from an SHP Health Service Partner\n\n\nKey Dates:\nApplications close: 3 July 2026\, 5:00pm AEST\nSuccessful applicants will be notified: August 2026\nGrants will commence: from January 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/shp-pilot-grants/
CATEGORIES:Grants,Discovery
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/06/SHP-Pilot-Grants-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260713T120000
DTEND;TZID=Australia/Sydney:20260713T120000
DTSTAMP:20260611T031340Z
CREATED:20260611T031340Z
LAST-MODIFIED:20260611T031340Z
UID:10000306-1783944000-1783944000@melanoma.org.au
SUMMARY:NSW Premier's Awards for Outstanding Cancer Research
DESCRIPTION:The Cancer Institute NSW is delighted to announce the return of the NSW Premier’s Awards for Outstanding Cancer Research\, a prestigious event that pays tribute to the remarkable accomplishments of individuals and teams within the cancer research community and those supporting innovation and cutting-edge delivery of care. \nNow is your chance to nominate an exceptional team or individual. The Outstanding Cancer Clinical Trials Unit Award is especially relevant to your work. \nThis Award recognises a high-performing cancer clinical trials unit in New South Wales that demonstrates operational excellence\, leadership in trial conduct\, and commitment to advancing access to cancer clinical trials. \nNominations are now open across nine award categories: \n• Outstanding Cancer Researcher of the Year Award \n• Outstanding Early Career Researcher Award \n• Outstanding Mid-Career Researcher Award \n• Rising Star PhD Candidate Award \n• Outstanding Cancer Clinical Trials Unit Award \n• Consumer Engagement in Cancer Research Award \n• Cancer Control Innovation Award \n• Improving Equitable Outcomes through Cancer Research Award \n• Reducing Cancer Inequality for Aboriginal People Award \nThese categories highlight progress and success in line with the strategic goals of the NSW Cancer Plan and NSW Aboriginal Cancer Strategy. \nThe winners will be announced at the NSW Premier’s Awards for Outstanding Cancer Research event to be held at 5.00pm Thursday 19 November 2026 at NSW Parliament House. \nAnyone involved in improving cancer patient outcomes within NSW is eligible to be nominated. \nKey date:\nNominations close 12pm (noon) Monday 13 July 2026. \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/premiers_awards_cancer_research/
CATEGORIES:Awards
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/06/Cancer_Institute-Premiers_Awards600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260714
DTEND;VALUE=DATE:20260729
DTSTAMP:20260728T235958Z
CREATED:20260401T234731Z
LAST-MODIFIED:20260728T235958Z
UID:10000282-1783987200-1785283199@melanoma.org.au
SUMMARY:MPA-MIA Community Webinar Series 2026
DESCRIPTION:Join us for an informative series of three live webinars for patients with melanoma and their carers. \nHosted by Melanoma Patients Australia (MPA) and Melanoma Institute Australia (MIA)\, each week our free webinar will provide you with a rare opportunity to hear from medical experts and community members as they focus on a different topic of interest each week. The webinar will conclude with a Q&A panel discussion. \nThe webinars are held every Tuesday evening for three weeks. Please click on the registration link below for each webinar that you’d like to attend. \nNote that the webinars are held from 7pm to 8pm AEST.\nCost: Free \nWebinar One: ‘Your melanoma nurse: What they do and how they help’ \nHeld on Tuesday 14 July \nSpeakers: \n\nPeta Holly\, Specialist Melanoma Telehealth Nurse\nRebecca Johnson\, National Melanoma Nurses Program Manager\nTed Mlynarz\, Patient Speaker\n\nWATCH RECORDINGWebinar Two: ‘Understanding endocrine side effects of immunotherapy’\nHeld on Tuesday 21 July \nSpeakers: \n\nDr Stephanie Zunder – Medical Oncologist\nDr Annabelle Hayes – Endocrinologist\nAled Gaynor – Medical Oncology Clinical Nurse Consultant\nCarmel Finnegan – Community member\n\nWATCH RECORDINGWebinar Three: ‘Understanding sentinel lymph node biopsies: Helping you decide’ \nHeld on Tuesday 28 July \nSpeakers: \n\nA/Prof Alexander van Akkooi – Surgical Oncologist\nShahn Coburn – Nurse Practitioner\nElla Ania – Community member\n\nWATCH RECORDING
URL:https://melanoma.org.au/event/mpa-mia-community-webinar-series-2026/
CATEGORIES:Education,Patient Education
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/04/MIAE0367-MIA-_-MPA_WEB-BANNER_1200x675-series.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260714T170000
DTEND;TZID=Australia/Sydney:20260714T170000
DTSTAMP:20260505T055930Z
CREATED:20260505T055930Z
LAST-MODIFIED:20260505T055930Z
UID:10000291-1784048400-1784048400@melanoma.org.au
SUMMARY:MRFF National Critical Research Infrastructure
DESCRIPTION:The 2026 National Critical Research Infrastructure initiative invests in research infrastructure to ensure Australian researchers find innovative solutions to complex health problems in areas of unmet medical need. This grant opportunity has four streams. \nStream 1 – Innovation enablers\nAddress an area of unmet medical need by promoting the development and implementation of new research infrastructure by supporting development and/or expansion of research enablers such as biobanks\, tissue repositories\, novel platforms\, and secure health data environments to create valuable research resources. \nStream 2 – Digitisation of health care\nTranslate or implement innovative artificial intelligence technologies into health applications that: \n\nbenefit multiple health disciplines/areas\ninvolve consumers in the research journey to ensure the research is applicable to the needs of the Australian community; and\nincrease artificial intelligence workforce capacity and capability\, particularly in relation to health\, through cross-sector and interdisciplinary collaboration.\n\nStream 3 – Co-investment partnerships\nUtilise co-investment (cash only) with the research sector\, state and/or territory governments\, and industry\, in significant critical research infrastructure (e.g. facilities\, personnel and equipment): \n\nto support development of research capacity\, capability and/or effectiveness in an area of unmet medical need\, or\nto enable Australian research using new platforms\, systems and services in an area of unmet medical need.\n\nStream 4 – mRNA technology enablers\nLeverage and enhance emerging mRNA technologies\, platforms\, and/or equipment to accelerate development of mRNA-based vaccines and therapeutics in an area of unmet medical need. \nGrants to fund research infrastructure projects\, up to $3 million in Streams 1\, 2 and 4\, and up to $7 million in Stream 3. \nAn application may only be submitted to one of the above four streams. Applicants must specify the stream to which they are applying in their application. \n\n\n\nKey Dates\nApplications close: 14 July 2026\nIndicative funding status: Funding anticipated to be awarded from December 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-research-infrastructure/
CATEGORIES:Grants,Infrastructure & Equipment
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF_Critical-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260722T170000
DTEND;TZID=Australia/Sydney:20260722T170000
DTSTAMP:20260505T060230Z
CREATED:20260505T060230Z
LAST-MODIFIED:20260505T060230Z
UID:10000292-1784739600-1784739600@melanoma.org.au
SUMMARY:MRFF BioMedTech Incubator
DESCRIPTION:The MRFF 2026 BioMedTech Incubator Program provides grants of financial assistance to support medical research and medical innovation projects through the establishment of BioMedTech Incubators. \nThis grant is for an eligible organisation who can establish a working incubator\, to partner with Australian small and medium enterprises (SMEs) to progress new and innovative medical research projects through the early stages of development. \nThe 2026 BioMedTech Grant Opportunity is part of the Medical Research Future Fund under the Medical Research Commercialisation Initiative. \nThis opportunity looks to fund suitable organisations to identify\, select and support Australian SMEs undertaking early-stage medical research and medical innovation projects that have commercial potential. \nThe intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by increasing the number of SMEs developing novel biomarkers\, diagnostics\, therapeutics\, assistive devices and/or digital technologies that have progressed through the early stages of research and development to the point where they are ‘de-risked’ and attractive to private investment for commercialisation. \nApplicants may propose to support development of innovations in their area/s of strength (i.e. applicants are not required to propose a program that covers the breadth of the biomedtech sector). \nGrants of up to $33 million to establish BioMedTech Incubators. \n\nKey Dates\nApplications close: 22 July 2026\nIndicative funding status: Funding anticipated to be awarded from December 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-incubator/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF_Incubator-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260723
DTEND;VALUE=DATE:20260726
DTSTAMP:20260331T012303Z
CREATED:20260331T012303Z
LAST-MODIFIED:20260331T012303Z
UID:10000278-1784764800-1785023999@melanoma.org.au
SUMMARY:ASDR Annual Scientific Meeting
DESCRIPTION:The Australasian Society for Dermatology Research (ASDR) is pleased to invite you to the ASDR 2026 Annual Scientific Meeting\, to be held in person from 23–25 July 2026 at the Westmead Innovation Centre\, Sydney\, Australia. The meeting will deliver a comprehensive scientific program featuring leading national and international experts\, highlighting recent progress and emerging directions in dermatology research. Key areas to be explored include: \n\nKeratinocyte and Squamous Cell Carcinomas\nMelanocyte/ Keratinocyte biology\nMicroenvironment\nFundamental Skin Research\nSkin immunology and immune disorders\nAutoimmune Disorders\nWound Healing and Stem Cells\nMelanoma and Pigmentation Disorders\nSkin Translational Research\n\nWe look forward to bringing together researchers\, clinicians\, and industry leaders to foster collaboration and discussion on the most innovative topics in dermatology research. \nLocation: Westmead Innovation Centre\, Sydney\, Australia \nKey Dates: \nAbstract Submission Deadline: 19 April 2026\nAbstract Outcomes: 15 May 2026\nEarly Bird Registration Deadline: 30 June 2026 at 23:59 AEST\nRegistration Deadline: 16 July 2026 at 23:59 AEST \nFIND OUT MORE
URL:https://melanoma.org.au/event/asdr-annual-meeting/
LOCATION:Westmead Innovation Centre\, Hawkesbury Rd\, Sydney\, NSW\, 2145\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/ASDR-ASM-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260724
DTEND;VALUE=DATE:20260726
DTSTAMP:20260129T023350Z
CREATED:20260129T022216Z
LAST-MODIFIED:20260129T023350Z
UID:10000238-1784851200-1785023999@melanoma.org.au
SUMMARY:Plastic Surgery Congress 2026
DESCRIPTION:Australian Society of Plastic Surgeons welcomes you to the 2026 Plastic Surgery Congress (PSC)\, where the future of plastic\, reconstructive\, and aesthetic surgery takes centre stage. \n​Taking place at the Sofitel Brisbane Central\, PSC 2026 promises a dynamic program packed with cutting-edge content\, world-class presentations\, and the latest global best practices. With two full days of medical education\, hands-on workshops\, and lively social events\, the Congress is designed to spark collaboration and professional growth. \n​In 2026\, delegates can expect an exceptional line-up of international and local faculty\, carefully curated to provide a truly bespoke educational experience. We have introduced a refreshed academic focus\, featuring topics not previously explored in depth at past congresses. These include burns\, peroneal reconstruction\, hands and brachial plexus surgery\, and aesthetics. And of course\, no congress held in Brisbane would be complete without a dedicated emphasis on skin cancer. \n​Expect an exceptional line-up of international and local experts who will showcase ground-breaking techniques and transformative ideas shaping the field today. \n​Key Dates \nAbstracts close: 9 February 2026 \nEarly bird registration closes: 22 April 2026 \nCongress Venue \nSofitel Brisbane Central \n249 Turbot Street Brisbane QLD 4000 AUSTRALIA​ \n​ \nFIND OUT MORE
URL:https://melanoma.org.au/event/psc_2026/
LOCATION:Sofitel Brisbane Central\, 249 Turbot Street\, Brisbane\, QLD\, 4000\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/01/PSC_2026-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260729
DTEND;VALUE=DATE:20260730
DTSTAMP:20260618T062838Z
CREATED:20260602T052609Z
LAST-MODIFIED:20260618T062838Z
UID:10000298-1785283200-1785369599@melanoma.org.au
SUMMARY:SHP Annual Forum
DESCRIPTION:As an NHMRC-accredited Research Translation Centre\, Sydney Health Partners leverages the collective strength of our partners to accelerate the adoption of evidence into practice. This year’s Forum explores how we can work together to build lasting impact through effective research translation\, strengthen clinician‑to‑researcher career pathways\, and ensure our research remains globally competitive and in alignment with the priorities of our healthcare system. \nReflecting on another successful year of research translation\, the Forum will also celebrate excellence through our annual awards\, and shine a light on the essential role of genuine consumer–researcher partnerships in shaping research that truly matters. \nKeynote speakers: \n\nAdjunct Professor Michael Nicholl\, Chief Executive\, Clinical Excellence Commission\nProfessor John Prins\, Dean\, Faculty of Medicine and Health\, University of Sydney\n\nLocation: Kerry Packer Education Centre\, Johns Hopkins Drive (Off Missenden Road)\, RPA Hospital Precinct\, Camperdown NSW \nKey Date: 1:00-5:00 pm\, Wednesday 29 July 2026 (followed by networking refreshments) \nFIND OUT MORE
URL:https://melanoma.org.au/event/shp-annual-forum/
LOCATION:Kerry Packer Education Centre\, John Hopkins Drive\, Camperdown\, NSW\, 2050\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/SHP_Forum-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260729T170000
DTEND;TZID=Australia/Sydney:20260729T170000
DTSTAMP:20260603T013901Z
CREATED:20260602T051412Z
LAST-MODIFIED:20260603T013901Z
UID:10000299-1785344400-1785344400@melanoma.org.au
SUMMARY:NHMRC Investigator Grants
DESCRIPTION:Investigator Grants provide the highest-performing researchers at all career stages with consolidated funding for their salary (if required) and a significant research support package. \nIn this way\, the Chief Investigator has flexibility to pursue important new research directions as they arise\, adjust their resources accordingly\, and to form collaborations as needed\, rather than being restricted to the scope of a specific research project. \nInvestigator Grants support: \n\nResearch across the 4 pillars of health and medical research: biomedical\, clinical\, public health and health services research.\nAll career stages: early career researchers\, mid-career researchers and established researchers\nResearchers with clinical responsibilities (such as clinicians\, public health and allied health practitioners)\nFull-time and part-time researchers.\n\nInvestigator Grants aim to: \n\nAllow flexibility for investigators to pursue important new research directions as they arise and to form collaborations as needed\nFoster innovative and creative research\nCreate opportunities for researchers at all career stages to establish their own research programs\nReduce application and peer review burden on researchers.\n\n\nKey Dates:\nApplications open: 3 June 2026\nMinimum data due: 1 July 2026\nApplications close: 29 July 2026\nProposed peer review: August – November 2026\nOutcomes to be advised: March 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nhmrc-investigator-grants/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/NHMRC-Investigator-Grants-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260731
DTEND;VALUE=DATE:20260801
DTSTAMP:20260624T035507Z
CREATED:20260624T035507Z
LAST-MODIFIED:20260624T035507Z
UID:10000308-1785456000-1785542399@melanoma.org.au
SUMMARY:The RACP Trainee Research Awards Symposium
DESCRIPTION:Join us in celebrating the next generation of physician researchers at the RACP Trainee Research Awards Symposium. \nHear outstanding trainees from across Australia and Aotearoa New Zealand present their innovative research in paediatric and adult medicine. We’ll be joined by our guest speaker\, renal and transplant physician\, Associate Professor Melanie Wyld\, alongside members of the College Research Grants Committee. \nAll members are welcome. The Symposium will be of particular interest to trainees who are considering\, starting or continuing a career in medical research. \nLocation: RACP Office\, 145 Macquarie Street\, Sydney / Online \n\nKey Date: Friday\, 31 July 2026 from 2.30pm to 6pm AEST \nFIND OUT MORE
URL:https://melanoma.org.au/event/racp-awards-symposium/
LOCATION:RACP\, 145 Macquarie Street\, Sydney\, NSW\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/06/RACP_Symposium-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260731T170000
DTEND;TZID=Australia/Sydney:20260731T170000
DTSTAMP:20260617T005042Z
CREATED:20260505T055547Z
LAST-MODIFIED:20260617T005042Z
UID:10000290-1785517200-1785517200@melanoma.org.au
SUMMARY:RACP Research Awards and Career Grants
DESCRIPTION:Through the RACP Foundation\, we’re able to offer financial support to Fellows and trainees pursuing careers in medical research. Over 50 different fellowships\, scholarships and grants are available annually\, totalling over $2.5 million in funding. \nCareer Development Fellowships are intended for mid-career researchers who completed their research higher degree over 7 years ago and/or researchers who are not eligible for either Research Entry Scholarship or Research Establishment Fellowships. \nResearch Establishment Fellowships are available to Fellows and Advanced Trainees who want to establish themselves in a research career. \nResearch Entry Scholarships provide up to $45\,000 stipend support to Advanced Trainees and Fellows who are at the start of their research careers\, helping them undertake a Masters\, PhD or equivalent higher degree and build a foundation for a future in medical research. \nResearch Development Grants provide from $10\,000 to $30\,000 in funding for smaller research projects for beginning researchers. Applicants can undertake a short-term or part-time research project. \nTravel Grants provide from $10\,000 to $30\,000 funding to support RACP trainees and Fellows undertaking short periods of research\, study or international collaboration. \n\nKey Dates\nApplications close:\nCareer Development & Research Establishment Fellowships: 30 June 2026\nResearch Entry Scholarships: 7 July 2026\nResearch Development Grants: 24 July 2026\nTravel Grants: 31 July 2026 \nOutcomes advised: December 2026 \nSEE WEBSITE
URL:https://melanoma.org.au/event/racp-awards-grants/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/RACP-Awards-and-Grants-600-x-338-px.jpg
END:VEVENT
END:VCALENDAR